Product Name:

NebuSelect™ Recombinant Human PADI4, His-tag

Catalog#:

NBL-240593

Description:

NebuSelect™ Recombinant Human PADI4, His-tag(Cat#NBL-240593) is expressed in E.coli with His tag at the N-Terminus.It contains Met1-Pro663.

Species:

Human

Expression System:

E.coli

Molecular Weight: 

The protein has a predicted MW of 76.6 kDa same as Bis-Tris PAGE result.

Target Name:

PADI4; Protein-arginine deiminase type-4; HL-60 PAD; HL60 PAD; HL-60; PAD; PAD4; PADI5; PDI5

Target Information:

Peptidylarginine deiminase type4 (PADI4) was firstly identified as a non-MHC RA genetic risk factor. Furthermore, PADI4 risk allele possessed the association with bone damage regardless of anti citrullinated peptide antibody (ACPA) positivity in Asian RA patients. PADI4 gene codes PAD4 protein which has post-translational modification activity (citrullination). Padi4 is mainly expressed in myeloid cells and granulocytes.

Amino Acid Sequence: 

Met1-Pro663

Purity:

＞95%

Formulation:

see COA

Endotoxin:

＜1EU/ug(LAL Method)

Storage: 

4°C for short term. 

-20°C for long term.

To get more information, please contact us freely.